The association of hypertension and aortic valve sclerosis

References

• Otto C. M., Lind B. K., Kitzman D. W., Gersh B. J., Siscovick D. S. Association of aortic‐valve sclerosis with cardiovascular mortality and morbidity in the elderly. New Engl J Med 1999; 341: 142–147
   PubMed Web of Science ®Google Scholar
• Aronow W. S., Ahn C., Shirani J., Kronzon I. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol 1999; 83: 599–600
   PubMed Web of Science ®Google Scholar
• Lindroos M., Kupari M., Heikkila J., Tilvis R. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21: 1220–1225
   PubMed Web of Science ®Google Scholar
• Stewart B. F., Siscovick D., Lind B. K., Gardin J. M., Gottdiener J. S., Smith V. E., et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29: 630–634
   PubMed Web of Science ®Google Scholar
• Rabkin S. W., Chu‐Chu‐Lin S. F. Epidemiology of valvular heart disease in Canada. Can J Cardiol 1988; 4: 412–416
   PubMed Web of Science ®Google Scholar
• Chan K. L. Is aortic stenosis a preventable disease?. J Am Coll Cardiol 2003; 42: 593–599
   PubMed Web of Science ®Google Scholar
• Joffres M. R., Hamet P., Rabkin S. W., Gelsky D., Hogan K., Fodor G. High blood pressure in Canadian adults: Prevalence, control and awareness. Can Med Assoc J 1992; 146: 28–36
   Web of Science ®Google Scholar
• Franklin S. S., Jacobs M. J., Wong N. D., L'Italien G. J., Lapuerta P. Predominance of isolated systolic hypertension among middle‐aged and elderly US hypertensives: Analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37: 869–874
   PubMed Web of Science ®Google Scholar
• Adler Y., Shemesh J., Tenenbaum A., Hovav B., Fisman E. Z., Motro M. Aortic valve calcium on spiral computed tomography (dual slice mode) is associated with advanced coronary calcium in hypertensive patients. Coronary Artery Disease 2002; 13: 209–213
   PubMed Web of Science ®Google Scholar
• Rabkin S. W., Sackett D. L. Epidemiology of arterial thromboembolism. Hemostasis and thrombosis, R. W Colman, J Hirsch, V. J Marder. Lippincott, Philadelphia 1982; 873–888
   Google Scholar
• Aronow W. S., Schwartz K. S., Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 1987; 59: 998–999
   PubMed Web of Science ®Google Scholar
• Pasierski T., Pearson A. C., Labovitz A. J. Pathophysiology of isolated systolic hypertension in elderly patients: Doppler echocardiographic insights. Am Heart J 1991; 1: 528–534
   Google Scholar
• Lindroos M., Kupari M., Valvanne J., Strandberg T., Heikkila J., Tilvis R. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1994; 15: 865–870
   PubMed Web of Science ®Google Scholar
• Boon A., Cheriex E., Lodder J., Kessels F. Cardiac valve calcification: Characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997; 78: 472–474
   PubMed Web of Science ®Google Scholar
• Fried L. P., Borhani N. O., Enright P., Furberg C. D., Gardin J. M., Kronmal R. A., et al. The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1991; 1: 263–276
   PubMedGoogle Scholar
• Agmon Y., Khandheria B. K., Meissner I., Sicks J. R., O'Fallon W. M., Wiebers D. O., et al. Aortic valve sclerosis and aortic atherosclerosis: Different manifestations of the same disease? Insights from a population‐based study. J Am Coll Cardiol 2001; 38: 827–834
   PubMed Web of Science ®Google Scholar
• Adler Y., Vaturi M., Wiser I., Shapira Y., Herz I., Weisenberg D., et al. Nonobstructive aortic valve calcium as a window to atherosclerosis of the aorta. Am J Cardiol 2000; 86: 68–71
   PubMed Web of Science ®Google Scholar
• Pomerance A., Darby A. J., Hodkinson H. M. Valvular calcification in the elderly: Possible pathogenic factors. J Gerontol 1978; 33: 672–675
   PubMedGoogle Scholar
• Gotoh T., Kuroda T., Yamasawa M., Nishinaga M., Mitsuhashi T., Seino Y., et al. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995; 76: 928–932
   PubMed Web of Science ®Google Scholar
• Wong N. D., Sciammarella M., Arad Y., Miranda‐Peats R., Polk D., Hachamovich R., et al. Relation of thoracic aortic and aortic valve calcium to coronary artery calcium and risk assessment. Am J Cardiol 2003; 92: 951–955
   PubMed Web of Science ®Google Scholar
• Hoagland P. M., Cook E. F., Flatley M., Walker C., Goldman L. Case–control analysis of risk factors for presence of aortic stenosis in adults (age 50 years or older). Am J Cardiol 1985; 55: 744–747
   PubMed Web of Science ®Google Scholar
• Mohler E. R 3rd., Gannon F., Reynolds C., Zimmerman R., Keane M. G., Kaplan F. S. Bone formation and inflammation in cardiac valves. Circulation 2001; 103: 1522–1528
   PubMed Web of Science ®Google Scholar
• Edwards J. E. On the etiology of calcific aortic stenosis. Circulation 1962; 26: 817–818
   Web of Science ®Google Scholar
• Roberts W. C. The hypertensive diseases. Evidence that systemic hypertension is a greater risk factor to the development of other cardiovascular diseases than previously suspected. Am J Med 1975; 59: 523–532
   PubMed Web of Science ®Google Scholar
• Thubrikar M., Piepgrass W. C., Shaner T. W., Nolan S. P. The design of the normal aortic valve. Am J Physiol 1981; 241: H795–801
   Google Scholar
• Otto C. M., Kuusisto J., Reichenbach D. D., Gown A. M., O'Brien K. D. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90: 844–853
   PubMed Web of Science ®Google Scholar
• O'Brien K. D., Reichenbach D. D., Marcovina S. M., Kuusisto J., Alpers C. E., Otto C. M. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of ‘degenerative’ valvular aortic stenosis. Arteriosclerosis, Thromb Vasc Biol 1996; 16: 523–532
   PubMed Web of Science ®Google Scholar
• Roberts W. C. The senile cardiac calcification syndrome. Am J Cardiol 1986; 58: 572–574
   PubMed Web of Science ®Google Scholar
• Stein P. D., Sabbah H. N., Pitha J. V. Continuing disease process of calcified aortic stenosis. Role of microthrombi and turbulent flow. Am J Cardiol 1977; 39: 159–163
   PubMed Web of Science ®Google Scholar
• Thubrikar M. J., Deck J. D., Aouad J., Chen J. M. Intramural stress as a causative factor in atherosclerotic lesions of the aortic valve. Atherosclerosis 1985; 55: 299–311
   PubMed Web of Science ®Google Scholar
• Drolet M. C., Arsenault M., Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 2003; 41: 1211–1217
   PubMed Web of Science ®Google Scholar
• Walton K. W., Williamson N., Johnson A. G. The pathogenesis of atherosclerosis of the mitral and aortic valves. J Pathol 1970; 101: 205–220
   PubMed Web of Science ®Google Scholar
• Aronow W. S., Ahn C., Kronzon I., Goldman M. E. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001; 88: 693–695
   PubMed Web of Science ®Google Scholar
• Shavelle D. M., Takasu J., Budoff M. J., Mao S. S., Zhao X‐Q., O'Brien K. D. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 2002; 359: 1125–1126
   PubMed Web of Science ®Google Scholar
• Bellamy M. F., Pellikka P. A., Klarich K. W., Tajik A. J., Enriquez‐Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme‐A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002; 40: 1723–1730
   PubMed Web of Science ®Google Scholar
• Kim K. M., Valigorsky J. M., Mergner W. J., Jones R. T., Pendergrass R. F., Trump B. F. Aging changes in the human aortic valve in relation to dystrophic calcification. Human Pathol 1976; 7: 47–60
   PubMed Web of Science ®Google Scholar
• Schiffrin E. L. Beyond blood pressure: The endothelium and atherosclerosis progression. Am J Hypertension 2002; 15: 115S–122S
   PubMed Web of Science ®Google Scholar
• Poggianti E., Venneri L., Chubuchny V., Jambrik Z., Baroncini L. A., Picano E. Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol 2003; 41: 136–141
   PubMed Web of Science ®Google Scholar
• Safar M. E., London G. M., Asmar R., Frohlich E. D. Recent advances on large arteries in hypertension. Hypertension 1998; 32: 156–161
   PubMed Web of Science ®Google Scholar
• Robicsek F., Thubrikar M. J., Fokin A. A. Cause of degenerative disease of the trileaflet aortic valve: Review of subject and presentation of a new theory. Ann Thorac Surg 2002; 73: 1346–1354
   PubMed Web of Science ®Google Scholar
• O'Brien K. D., Shavelle D. M., Caulfield M. T., McDonald T. O., Olin‐Lewis K., Otto C. M., et al. Association of angiotensin‐converting enzyme with low‐density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002; 106: 2224–2230
   PubMed Web of Science ®Google Scholar
• Olsen M. H., Wachtell K., Bella J. N., Boman K., Gerts E., Papademetriou V., et al. The effect of losartan versus atenolol on aortic valve sclerosis: A LIFE substudy (abstract). J Am Coll Cardiol 2003; 41: 505A
   Web of Science ®Google Scholar
• O'Brien K. D., Kuusisto J., Reichenbach D. D., Ferguson M., Giachelli C., Alpers C. E., et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995; 92: 2163–2168
   PubMed Web of Science ®Google Scholar
• Mohler E. R 3rd., Adam L. P., McClelland P., Graham L., Hathaway D. R. Detection of osteopontin in calcified human aortic valves. Arteriosclerosis, Thromb Vasc Biol 1997; 17: 547–552
   PubMed Web of Science ®Google Scholar
• Srivatsa S. S., Harrity P. J., Maercklein P. B., Kleppe L., Veinot J., Edwards W. D., et al. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest 1997; 99: 996–1009
   PubMed Web of Science ®Google Scholar
• Rajamannan N. M., Subramaniam M., Springett M., Sebo T. C., Niekrasz M., McConnell J. P., et al. Atorvastatin inhibits hypercholesterolemia‐induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002; 105: 2660–2665
   PubMed Web of Science ®Google Scholar
• Steitz S. A., Speer M. Y., McKee M. D., Liaw L., Almeida M., Yang H., et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 2002; 161: 2035–2046
   PubMed Web of Science ®Google Scholar
• Thomas S. E., Lombardi D., Giachelli C., Bohle A., Johnson R. J. Osteopontin expression, tubulointerstitial disease, and essential hypertension. Am J Hypertens 1998; 11: 954–961
   PubMed Web of Science ®Google Scholar
• Satta J., Melkko J., Pollanen R., Tuukkanen J., Paakko P., Ohtonen P., et al. Progression of human aortic valve stenosis is associated with tenascin‐C expression. J Am Coll Cardiol 2002; 39: 96–101
   PubMed Web of Science ®Google Scholar
• Mackie E. J., Scott‐Burden T., Hahn A. W., Kern F., Bernhardt J., Regenass S., et al. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol 1992; 14: 377–388
   Google Scholar